Compounds > plicamycin
Page last updated: 2024-08-23

plicamycin and tolfenamic acid

plicamycin has been researched along with tolfenamic acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, DZ; Gao, Y; Huang, S; Jia, Z; Le, X; Li, Q; Wang, L; Wei, D; Xie, K; Yao, JC; Zhang, J1
Chou, TC1

Other Studies

2 other study(ies) available for plicamycin and tolfenamic acid

ArticleYear
Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity.
    Cancer research, 2010, Feb-01, Volume: 70, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Body Weight; Cell Line, Tumor; Chromatin Immunoprecipitation; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; ortho-Aminobenzoates; Pancreatic Neoplasms; Plicamycin; Promoter Regions, Genetic; Protein Binding; Sp1 Transcription Factor; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2010
Combined treatment of pancreatic cancer with mithramycin a and tolfenamic Acid promotes sp1 degradation and synergistic antitumor activity--letter.
    Cancer research, 2011, Apr-01, Volume: 71, Issue:7

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Humans; ortho-Aminobenzoates; Pancreatic Neoplasms; Plicamycin; Sp1 Transcription Factor

2011